Showing results (911-920 of 2,282) with videos related to
Sort By:
Pageof 229
HIV Medicine|January 9, 2013
Incident hypertension in older women and men with or at risk for HIV infectionS H Factor, Y Lo, E Schoenbaum, et al.HIV Medicine|September 19, 2014
HIV status and viral loads among men testing positive for rectal gonorrhoea and chlamydia, Maricopa County, Arizona, USA, 2011-2013M M Taylor, D R Newman, J Gonzalez, et al.HIV Medicine|September 25, 2014
Increased T-cell turnover is associated with spondyloarthritis in virally suppressed patients with HIV-1 infectionI-N Lu, D Meyer-Olson, M Stoll, et al.HIV Medicine|September 25, 2014
Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort studyC Hoffmann, M Hentrich, D Gillor, et al.HIV Medicine|October 10, 2014
How to address smoking cessation in HIV patientsM Calvo-Sánchez, E MartinezHIV Medicine|January 20, 2012
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physiciansM Huber, B Ledergerber, R Sauter, et al.HIV Medicine|March 16, 2012
Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 substudyM A Valantin, S Kolta, P Flandre, et al.HIV Medicine|December 20, 2014
Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approachC Iniesta-Navalón, J J Franco-Miguel, J J Gascón-Cánovas, et al.HIV Medicine|March 4, 2016
Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapyV Estrada, S Monge, M D Gómez-Garre, et al.HIV Medicine|December 15, 2015
Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trialE Wilkins, M Fisher, A J Brogan, et al.Pageof 229